9.1
[1]. Nord CE, et al. Tinidazole--microbiology, pharmacology and efficacy in anaerobic infections. Infection. 1983;11(1):4-.
[2]. Bhanu Sud, et al. Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanide. J Okla State Med Assoc. 27 Jul;1(7):27-72.
[3]. Carlos E Granados, et al. Drugs for treating giardiasis. Cochrane Database Syst Rev. 212 Dec 12;12(12):CD7787.
[4]. Gil M Penuliar, et al. Phenotypic and transcriptional profiling in Entamoeba histolytica reveal costs to fitness and adaptive responses associated with metronidazole resistance. Front Microbiol. 21 May ::34.
[]. Guo-Xia Zheng, et al. An integrated microfludic device for culturing and screening of Giardia lamblia. Exp Parasitol. 214 Feb:137:1-7.
H312+H332-H341-H31
P21-P271-P28-P32+P32-P34+P34-P32+P34-P4-P1
GHS7,GHS8